BSE and BCOS guideline for transthoracic echocardiographic assessment of adult cancer patients receiving anthracyclines and/or trastuzumab
Dobson, Rebecca Ghosh, Arjun K Ky, Bonnie Marwick, Tom Stout, Martin Harkness, Allan Steeds, Rick Robinson, Shaun Oxborough, David Adlam, David
Dobson, Rebecca
Ghosh, Arjun K
Ky, Bonnie
Marwick, Tom
Stout, Martin
Harkness, Allan
Steeds, Rick
Robinson, Shaun
Oxborough, David
Adlam, David
Abstract
The subspecialty of cardio-oncology aims to reduce cardiovascular morbidity and mortality in patients with cancer or following cancer treatment. Cancer therapy can lead to a variety of cardiovascular complications, including left ventricular systolic dysfunction, pericardial disease, and valvular heart disease. Echocardiography is a key diagnostic imaging tool in the diagnosis and surveillance for many of these complications. The baseline assessment and subsequent surveillance of patients undergoing treatment with anthracyclines and/or human epidermal growth factor receptor (HER) 2-positive targeted treatment (e.g., trastuzumab and pertuzumab) form a significant proportion of cardio-oncology patients undergoing echocardiography. This guideline from the British Society of Echocardiography and British Cardio-Oncology Society outlines a protocol for baseline and surveillance echocardiography of patients undergoing treatment with anthracyclines and/or trastuzumab. The methodology for acquisition of images and the advantages and disadvantages of techniques are discussed. Echocardiographic definitions for considering cancer therapeutics-related cardiac dysfunction are also presented.
MIDER Authors
Citations
Altmetric:
Date
2021-03-16
Type
Article
Subject
Cardiology, Oncology. Pathology., Radiology, Practice of medicine
Citation
Dobson R, Ghosh AK, Ky B, Marwick T, Stout M, Harkness A, Steeds R, Robinson S, Oxborough D, Adlam D, Stanway S, Rana B, Ingram T, Ring L, Rosen S, Plummer C, Manisty C, Harbinson M, Sharma V, Pearce K, Lyon AR, Augustine DX; British Society of Echocardiography (BSE) and theBritish Society of Cardio-Oncology (BCOS). BSE and BCOS Guideline for Transthoracic Echocardiographic Assessment of Adult Cancer Patients Receiving Anthracyclines and/or Trastuzumab. JACC CardioOncol. 2021 Mar 16;3(1):1-16. doi: 10.1016/j.jaccao.2021.01.011.
Journal / Source Title
JACC CardioOncology
DOI
10.1016/j.jaccao.2021.01.011
PMID
34396303
Publisher
Elsevier
Publisher’s URL
https://www.jacc.org/journal/cardio-oncology